Biostar Pharmaceuticals, Inc. Announces 2012 Second Quarter Financial Results
News | 14 August 2012
14, 2012 /PRNewswire-Asia/ ? Biostar Pharmaceuticals, Inc. (NASDAQ GM: BSPM) (?Biostar? or ?the Company?), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China for a variety of diseases and conditions, ...
Click on the link to read the full article at RedOrbit
(This link will open in a new window)
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
